Research Topic

Anti-cancer drug induced cardiotoxicity

About this Research Topic

Cardiovascular disease (CVD) remains the leading cause of death worldwide. An emerging contributory factor to the global burden of CVD is the impact that certain chronic medications may have on cardiovascular function. Indeed, the possibility of non-specific or off-target effects of non-cardiac drugs on the ...

Cardiovascular disease (CVD) remains the leading cause of death worldwide. An emerging contributory factor to the global burden of CVD is the impact that certain chronic medications may have on cardiovascular function. Indeed, the possibility of non-specific or off-target effects of non-cardiac drugs on the heart is an ongoing concern for safety pharmacology in the pharmaceutical industry with enormous long term impact both socially and economically.

Anti-cancer drugs in particular have received widespread attention due to reports of off-target detrimental effects on cardiovascular function. Although many new anti-cancer drugs have significantly improved survival rates from cancer, there is evidence for a growing number of patients presenting with cardiovascular complications as a consequence of their therapeutic intervention. Depending on the anti-cancer agent in question, these effects can range from pericardial complication, thromboembolic disease and hypertension to arrhythmias and left ventricular failure and can occur in patients who have no prior history of CVD. The situation is made even more complex by the fact that the anti-cancer drug effect can be influenced by patient age, underlying co-morbidities as well as whether the patient has also received radiotherapy.

This phenomenon of `anti-cancer drug cardiotoxicity' has given birth to a new clinical discipline called cardio-oncology. This interdisciplinary approach to patient care combines cardiology and oncology and has resulted in more effective patient management going forward. That said, anti-cancer drug cardiotoxicity is a growing global challenge. The number of new anti-cancer drugs continues to increase and we still do not fully understand why or how many of these drugs will be cardiotoxic. The true extent of the overall risk to cancer patients is unknown and the underlying mechanism(s) responsible for the cardiotoxic effects remain to be fully identified. Strategies to prevent or mitigate cardiotoxicity resulting from cancer treatment are urgently needed to ensure the best cancer care possible. Future management of anticancer drug-related cardiotoxicity will rely on improved understanding of the cellular effects of these agents in the heart and vasculature. This, combined with improved biomarker identification and cardiac imaging for monitoring purposes, will be crucial in an overarching strategy to design effective cardioprotective agents that can reduce or reverse the cardiotoxic effects.

This research topic is open to either original research papers or review articles in the area of anti-cancer drug induced cardiotoxicity. We are particularly keen to receive articles that focus on the following areas:
(i) Identifying the cellular mechanisms that contribute to the cardiotoxic response.
(ii) Understanding the effects that anti-cancer drugs have on different cell types of the heart and vasculature.
(iii) Insight into strategies that may reduce or reverse cardiotoxic effects.
(iv) Development and successful use of different models for effectively studying anti-cancer drug-induced effects (either in vitro or in vivo).


Keywords: Toxicity, Cardiac, Vascular, Cancer, Therapeutics


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 December 2020 Manuscript
31 January 2021 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 December 2020 Manuscript
31 January 2021 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..